Albuterol Sulfate Patent Expiration
Albuterol Sulfate was first introduced by Schering Corp Sub Schering Plough Corp
Albuterol Sulfate Patents
Given below is the list of patents protecting Albuterol Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Proair Digihaler | US11266796 | Inhalation device with integrated electronics | Feb 22, 2041 | Teva Branded Pharm |
| Proair Digihaler | US11173259 | Drug delivery device with electronics and power management | Jul 06, 2040 | Teva Branded Pharm |
| Proair Digihaler | US11464923 | Inhaler system | Jun 19, 2040 | Teva Branded Pharm |
| Proair Digihaler | US11439777 | Drug delivery device with electronics | May 24, 2040 | Teva Branded Pharm |
| Proair Digihaler | US11344685 | Drug delivery device with electronics | Sep 26, 2039 | Teva Branded Pharm |
| Proair Digihaler | US11000653 | Inhaler | Dec 18, 2038 | Teva Branded Pharm |
| Proair Digihaler | US11357935 | Drug delivery device with electronics | Sep 24, 2038 | Teva Branded Pharm |
| Proair Digihaler | US11351317 | Drug delivery device with electronics | Feb 10, 2038 | Teva Branded Pharm |
| Proair Digihaler | US10569034 | Compliance monitoring module for a breath-actuated inhaler | Aug 16, 2036 | Teva Branded Pharm |
| Proair Digihaler | US10918816 | Compliance monitoring module for a breath-actuated inhaler | Dec 14, 2035 | Teva Branded Pharm |
| Proair Digihaler | US9782550 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Branded Pharm |
| Proair Digihaler | US9782551 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Branded Pharm |
| Proair Respiclick | US9782550 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Branded Pharm |
| Proair Respiclick | US9782551 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Branded Pharm |
| Proair Digihaler | US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jan 13, 2032 | Teva Branded Pharm |
| Proair Respiclick | US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jan 13, 2032 | Teva Branded Pharm |
| Proair Digihaler | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Branded Pharm |
| Proair Hfa | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Branded Pharm |
| Proair Respiclick | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Branded Pharm |
| Proair Digihaler | US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jun 28, 2031 | Teva Branded Pharm |
| Proair Respiclick | US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jun 28, 2031 | Teva Branded Pharm |
| Proair Digihaler | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Proair Digihaler | US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Digihaler | US9731087 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US10022509 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US10086156 | Dose counter for inhaler and method for counting doses | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US9463289 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US9808587 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Respiclick | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Proair Respiclick | US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Respiclick | US9731087 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US8132712 | Metered-dose inhaler | Sep 07, 2028 | Teva Branded Pharm |
| Proair Digihaler | US8651103 | Dry powder inhalation apparatus | Mar 26, 2028 | Teva Branded Pharm |
| Proair Respiclick | US8651103 | Dry powder inhalation apparatus | Mar 26, 2028 | Teva Branded Pharm |
| Ventolin Hfa |
US7500444 (Pediatric) | Actuation indicator for a dispensing device | Jul 04, 2025 | Glaxosmithkline |
| Proair Digihaler | US10765820 | Dry powder inhalation apparatus |
May 19, 2025
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US9463288 | Dry powder inhalation apparatus |
May 19, 2025
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US10765820 | Dry powder inhalation apparatus |
May 19, 2025
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US9463288 | Dry powder inhalation apparatus |
May 19, 2025
(Expired) | Teva Branded Pharm |
| Ventolin Hfa | US7500444 | Actuation indicator for a dispensing device |
Jan 04, 2025
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US7832351 (Pediatric) | Actuation indicator for a dispensing device |
Dec 19, 2023
(Expired) | Glaxosmithkline |
| Proair Hfa | US7105152 | Suspension aerosol formulations |
Sep 12, 2023
(Expired) | Teva Branded Pharm |
| Ventolin Hfa | US7832351 | Actuation indicator for a dispensing device |
Jun 19, 2023
(Expired) | Glaxosmithkline |
| Proair Digihaler | US7540282 | Reservoir pressure system for medicament inhaler |
May 06, 2023
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US7540282 | Reservoir pressure system for medicament inhaler |
May 06, 2023
(Expired) | Teva Branded Pharm |
| Accuneb | US6702997 | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
Dec 28, 2021
(Expired) | Norvium Bioscience |
| Ventolin Hfa |
US6743413 (Pediatric) | Suspension aerosol formulations |
Dec 01, 2021
(Expired) | Glaxosmithkline |
| Proair Digihaler | US6701917 | Dose counter for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US6718972 | Dose metering system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US8006690 | Reservoir pressure system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6701917 | Dose counter for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6718972 | Dose metering system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US8006690 | Reservoir pressure system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Ventolin Hfa | US6743413 | Suspension aerosol formulations |
Jun 01, 2021
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US9861771 | Device housing for an aerosol container |
Oct 11, 2020
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US7350676 (Pediatric) | Valve for aerosol container |
Feb 24, 2019
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6431168 (Pediatric) | Dispenser with doses′ counter |
Dec 08, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US7107986 (Pediatric) | Dispenser with doses' counter |
Dec 06, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US7350676 | Valve for aerosol container |
Aug 24, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6161724 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6435372 (Pediatric) | Delivery system for a medicament and method for the assembly thereof |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6938796 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6997349 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US7143908 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6170717 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6315173 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6510969 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6966467 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6431168 | Dispenser with doses′ counter |
Jun 08, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US7107986 | Dispenser with doses' counter |
Jun 08, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6161724 | Indicating device |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6435372 | Delivery system for a medicament and method for the assembly thereof |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6938796 | Indicating device |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6997349 | Indicating device |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US7143908 | Indicating device |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6170717 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6315173 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6510969 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6966467 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxosmithkline |
| Proair Hfa | US6446627 | Inhaler dose counter |
Dec 18, 2017
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6446627 | Inhaler dose counter |
Dec 18, 2017
(Expired) | Teva Branded Pharm |
| Ventolin Hfa |
US6558651 (Pediatric) | Aerosols containing annealed particulate salbutamol and tetrafluoroethane |
Jun 19, 2017
(Expired) | Glaxosmithkline |
| Proair Hfa | US7566445 | Medicinal aerosols and methods of delivery thereof |
Jun 04, 2017
(Expired) | Teva Branded Pharm |
| Proair Hfa | US8834849 | Medicinal aerosols and methods of delivery thereof |
Jun 04, 2017
(Expired) | Teva Branded Pharm |
| Proventil-hfa | US6006745 | Device for delivering an aerosol |
Dec 28, 2016
(Expired) | Kindeva |
| Ventolin Hfa | US6558651 | Aerosols containing annealed particulate salbutamol and tetrafluoroethane |
Dec 19, 2016
(Expired) | Glaxosmithkline |
| Proventil-hfa | US5775321 | Seal configuration for aerosol canister |
Jul 07, 2015
(Expired) | Kindeva |
| Ventolin Hfa |
US6596260 (Pediatric) | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb 10, 2015
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6596260 | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug 10, 2014
(Expired) | Glaxosmithkline |
| Proair Hfa | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Teva Branded Pharm |
| Proventil-hfa | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Kindeva |
Albuterol Sulfate's Family Patents
Explore Our Curated Drug Screens
Albuterol Sulfate Generic API Manufacturers
Several generic applications have been filed for Albuterol Sulfate. The first generic version for Albuterol Sulfate was by Sandoz Inc and was approved on Dec 5, 1989. And the latest generic version is by The Ritedose Corp and was approved on Mar 12, 2025.
Given below is the list of companies who have filed for Albuterol Sulfate generic, along with the locations of their manufacturing plants worldwide.
1. ACERTIS PHARMS
Acertis Pharmaceuticals Llc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Acertis Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Oct 26, 2018 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Oct 26, 2018 |
2. ACTAVIS MID ATLANTIC
Actavis Mid Atlantic Llc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Sep 26, 1995 |
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Mar 30, 1999 |
3. AIZANT
Aizant Drug Research Solutions Private Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Aizant.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | BX | Mar 15, 2019 |
| EQ 4MG BASE | tablet | Prescription | ORAL | BX | Mar 15, 2019 |
Manufacturing Plant Locations New
Aizant's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aizant as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
4. AM THERAP
American Therapeutics Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Am Therap.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
5. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | May 12, 2010 |
6. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | May 21, 2018 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | May 21, 2018 |
7. APOTEX INC
Apotex Inc has filed for 4 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution | Discontinued | INHALATION | N/A | Apr 1, 2003 |
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Feb 2, 2007 |
| EQ 0.021% BASE | solution | Discontinued | INHALATION | N/A | Apr 5, 2010 |
| EQ 0.042% BASE | solution | Discontinued | INHALATION | N/A | Apr 5, 2010 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
8. ARMSTRONG PHARMS
Armstrong Pharmaceuticals Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Armstrong Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB2 | May 21, 2024 |
9. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | May 14, 2020 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | May 14, 2020 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
10. BAUSCH
Bausch Health Us Llc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Bausch.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution | Discontinued | INHALATION | N/A | Jun 18, 1998 |
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Mar 29, 2000 |
Manufacturing Plant Locations New
Bausch's manufacturing plants are situated in 2 countries - United States, Canada. Given below are the details of these plant locations as well as the firm names of Bausch as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||
| Canada |
| |||||||||||||||||||||||||||
11. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | Dec 27, 2006 |
12. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | Jun 26, 2007 |
13. CIPLA
Cipla Ltd has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB1 | Apr 8, 2020 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
14. COPLEY PHARM
Copley Pharmaceutical Inc has filed for 4 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Copley Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Nov 22, 1991 |
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Nov 22, 1991 |
| EQ 0.5% BASE | solution | Discontinued | INHALATION | N/A | Nov 27, 1991 |
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | May 28, 1993 |
15. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Sep 25, 1995 |
Manufacturing Plant Locations New
Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
16. DASH PHARMS NATCO
Dash Pharmaceuticals Llc A Fully Owned Sub Of Natco Pharma Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Dash Pharms Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Jan 17, 1991 |
| EQ 4MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Jan 17, 1991 |
17. DAVA PHARMS INC
Dava Pharmaceuticals Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Dava Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 20, 1989 |
18. EPIC PHARMA LLC
Epic Pharma Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Feb 9, 1999 |
19. HIBROW HLTHCARE
Hibrow Healthcare Private Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Hibrow Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Oct 8, 2020 |
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Oct 8, 2020 |
20. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Jan 30, 1998 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
21. LANDELA PHARM
Landela Pharmaceutical has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Landela Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Apr 4, 2006 |
22. LEXENPHARM
Lexenpharm Suzhou Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Lexenpharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.021% BASE | solution | Prescription | INHALATION | AN | May 3, 2024 |
| EQ 0.042% BASE | solution | Prescription | INHALATION | AN | May 3, 2024 |
23. LUOXIN AUROVITAS
Luoxin Aurovitas Pharma Chengdu Co Ltd has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Luoxin Aurovitas.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Prescription | INHALATION | AN | Oct 17, 2017 |
| EQ 0.042% BASE | solution | Prescription | INHALATION | AN | Apr 20, 2020 |
| EQ 0.021% BASE | solution | Prescription | INHALATION | AN | Apr 20, 2020 |
24. LUPIN
Lupin Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB2 | Aug 24, 2020 |
Manufacturing Plant Locations New
Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||||||||
25. MOVA
Mova Pharmaceuticals Corp has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Mova.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Sep 30, 1994 |
26. NEPHRON
Nephron Pharmaceuticals Corp has filed for 4 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Nephron.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE
(reference standard) | solution | Prescription | INHALATION | AN | Sep 17, 1997 |
| EQ 0.5% BASE
(reference standard) | solution | Prescription | INHALATION | AN | Jun 26, 2001 |
| EQ 0.042% BASE
(reference standard) | solution | Prescription | INHALATION | AN | Jun 28, 2004 |
| EQ 0.021% BASE | solution | Prescription | INHALATION | AN | Mar 31, 2010 |
Manufacturing Plant Locations New
Nephron's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Nephron as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
27. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution | Discontinued | INHALATION | N/A | Feb 21, 1992 |
28. PADAGIS US
Padagis Us Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB2 | Feb 24, 2020 |
Manufacturing Plant Locations New
Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
29. PLIVA
Pliva Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Pliva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
Manufacturing Plant Locations New
Pliva's manufacturing plants are situated in 3 countries - Croatia, United States, Czech Republic. Given below are the details of these plant locations as well as the firm names of Pliva as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Croatia |
| |||||
| United States |
| |||||
| Czech Republic |
| |||||
30. QUAGEN
Quagen Pharmaceuticals Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Quagen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | Sep 6, 2019 |
Manufacturing Plant Locations New
Quagen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Quagen as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
31. RISING
Rising Pharma Holdings Inc has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Jun 29, 2018 |
| EQ 8MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jan 29, 2007 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Jun 29, 2018 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
32. RITEDOSE CORP
The Ritedose Corp has filed for 4 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Ritedose Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Prescription | INHALATION | AN | Dec 16, 2008 |
| EQ 0.021% BASE
(reference standard) | solution | Prescription | INHALATION | AN | Dec 28, 2021 |
| EQ 0.042% BASE | solution | Prescription | INHALATION | AN | Dec 28, 2021 |
| EQ 0.5% BASE | solution | Prescription | INHALATION | AN | Mar 12, 2025 |
33. ROXANE
Roxane Laboratories Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Roxane.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Feb 13, 2001 |
34. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB1 | Jun 1, 2021 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Austria |
| |||||
| United States |
| |||||
| Spain |
| |||||
| India |
| |||||
35. SENTISS
Sentiss Ag has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Sentiss.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution | Prescription | INHALATION | AN | Jan 15, 1998 |
Manufacturing Plant Locations New
Sentiss's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Sentiss as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
36. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Albuterol Sulfate. Out of these eq 4mg base version comes by the name VOSPIRE ER, eq 8mg base version comes by the name VOSPIRE ER. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 20, 1989 |
| EQ 4MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 26, 2002 |
| EQ 8MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 26, 2002 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
37. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Prescription | INHALATION | AN | Jul 21, 2017 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
38. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Dec 5, 1989 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Dec 5, 1989 |
39. TEVA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Jun 25, 1993 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Jun 25, 1993 |
| EQ 2MG BASE/5ML
(reference standard) | syrup | Prescription | ORAL | AA | Mar 30, 1992 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| India |
| |||||||||
| Canada |
| |||||||||
| Czech Republic |
| |||||||||
| Ireland |
| |||||||||
| Israel |
| |||||||||
40. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Nov 9, 1999 |
41. UCB INC
Ucb Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Ucb Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Sep 29, 1992 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Sep 29, 1992 |
42. WARNER CHILCOTT
Warner Chilcott Div Warner Lambert Co has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Warner Chilcott.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Jan 9, 1990 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Jan 9, 1990 |
Manufacturing Plant Locations New
Warner Chilcott's manufacturing plants are situated in 2 countries - United States, Germany. Given below are the details of these plant locations as well as the firm names of Warner Chilcott as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||
| Germany |
| |||||||
43. WATSON LABS
Watson Laboratories Inc has filed for 5 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Aug 28, 1991 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Aug 28, 1991 |
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Apr 29, 1993 |
| EQ 0.042% BASE | solution | Discontinued | INHALATION | N/A | Sep 25, 2007 |
| EQ 0.021% BASE | solution | Discontinued | INHALATION | N/A | Sep 25, 2007 |
44. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Nov 24, 2003 |
45. WOCKHARDT EU OPERATN
Wockhardt Eu Operations Swiss Ag has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Wockhardt Eu Operatn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Nov 22, 1999 |
46. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Oct 22, 2020 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Oct 22, 2020 |